Epigenetic mechanisms of rapid-acting antidepressants
Open accessThe DOI matches its Crossref record; 270 of the 272 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Rapid-acting antidepressants (RAADs), including dissociative anesthetics, psychedelics, and empathogens, elicit rapid and sustained therapeutic improvements in psychiatric disorders by purportedly modulating neuroplasticity, neurotransmission, and immunity. These outcomes may be mediated by, or result in, an acute and/or sustained entrainment of epigenetic processes, which remodel chromatin structure and alter DNA accessibility to regulate gene expression. METHODS: In this perspective, we present an overview of the known mechanisms, knowledge gaps, and future directions surrounding the epigenetic effects of RAADs, with a focus on the regulation of stress-responsive DNA and brain regions, and on the comparison with conventional antidepressants. MAIN BODY: Preliminary correlative evidence indicates that administration of RAADs is accompanied by epigenetic effects which are similar to those elicited by conventional antidepressants. These include changes in DNA methylation, post-translational modifications of histones, and differential regulation of non-coding RNAs in stress-responsive chromatin areas involved in neurotrophism, neurotransmission, and immunomodulation, in stress-responsive brain regions. Whether these epigenetic changes causally contribute to the therapeutic effects of RAADs, are a consequence thereof, or are unrelated, remains unknown. Moreover, the potential cell type-specificity and mechanisms involved are yet to be fully elucidated. Candidate mechanisms include neuronal activity- and serotonin and Tropomyosine Receptor Kinase B (TRKB) signaling-mediated epigenetic changes, and direct interaction with DNA, histones, or chromatin remodeling complexes. CONCLUSION: Correlative evidence suggests that epigenetic changes induced by RAADs accompany therapeutic and side effects, although causation, mechanisms, and cell type-specificity remain largely unknown. Addressing these research gaps may lead to the development of novel neuroepigenetics-based precision therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, ketamine reduces the hypermethylation of the BDNF gene promoter, a process often heightened in stress-related conditions, thereby enhancing BDNF transcription and promoting neuroplasticity [64].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [64]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Epigenetic Enhancement of BDNF Signaling Rescues Synaptic Plasticity in Aging
Zeng, Y., Tan, M., Kohyama, J., Sneddon, M., Watson, J. B., Sun, Y. E., & Xie, C.-W. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3878-11.2011 · Cited by 124
RetractedNon-coding RNAs in human disease
Esteller, M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3074 · Cited by 4,825
The multilayered complexity of ceRNA crosstalk and competition
Tay, Y., Rinn, J., & Pandolfi, P. P. (2014) · Nature · doi:10.1038/nature12986 · Cited by 3,910 · cited 1×
“Circular RNAs (circRNAs), ncRNAs generated by back-splicing, have extensive complementarity to target mRNAs and can encode proteins or increase the expression of the target gene(s) [163].”
BackgroundEpigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
McGowan, P. O., Sasaki, A., D'Alessio, A. C., Dymov, S., Labonté, B., Szyf, M., Turecki, G., & Meaney, M. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2270 · Cited by 3,531 · cited 1×
“Chromatin is a plastic entity, which adapts to external stimuli such as a changing environment and stress [1, 2].”
BackgroundDNA methylation and human disease
Robertson, K. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1655 · Cited by 2,864 · cited 1×
“This modi fi cation generally modulates transcription by inhibiting the binding of transcription factors or recruiting proteins involved in gene repression [27].”
BackgroundGriffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 1×
“Considering that psychedelic-assisted psychotherapy is a promising treatment to attenuate psychological and existential distress in individuals facing a life-threatening conditions such as cancer, it is important to assess the neoplastic potential of RAADs [254 – 256].”
BackgroundNibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 1×
“…promoters hypermethylation and circadian-related gene expression changes, coupled to cardiac hypertrophy and progressive damage MDMA abuse affects cardiac DNA methylation, and this might be involved in cardiotoxicity [217] and in vitro, while increasing BDNF and decreasing apoptosis [147 – 149].”
BackgroundNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 1×
“The outcome is the reopening of a period of structural and functional plasticity within the CNS that can be harnessed therapeutically [182 – 184, 189, 190].”
BackgroundSustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780 · cited 5×
“…causes an epigenetic remodeling of stress-responsive DNA and chromatin regions, and associated histone proteins in susceptible brain areas such as the ventral hippocampus [1, 5], amygdala [6], nucleus accumbens (NAc) [7], and the prefrontal cortex (PFC) [8] – dorsal raphe nucleus loop [9 – 11].”
BackgroundInfluentialNichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762 · cited 2×
“Rapid-acting antidepressants (referred herein as RAADs) are being investigated as novel therapeutics in psychiatry [14 – 16].”
BackgroundDNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405 · cited 2×
“…doses of psilocybin elicit DNA damage in the PFC [260] Hypothesis-Psilocybin might affect genetic aging via epigenetic regulation of telomere length Psilocybin might affect epigenetics processes involved with aging, preventing telomere degradation [68] A. Inserra et al. dissociation [169].”
BackgroundLasting epigenetic influence of early-life adversity on the BDNF gene
Roth, T. L., Lubin, F. D., Funk, A. J., & Sweatt, J. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.028 · Cited by 1,273 · cited 3×
“…of genes encoding the glucocorticoid receptor, arginin-vasopressin, and the brain-derived neurotrophic factor (BDNF) can be modulated by early-life adversities as early as 1 day after birth [28 – 43] and speci fi c cell types such as astrocytes carryover the epigenetic marks of stress [35, 44].”
BackgroundDerepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232 · cited 2×
“The membrane depolarization of cortical neurons results in chromatin remodeling and enhanced BDNF gene accessibility via a) decreased methylation of BDNF promoter III and IV [168, 169], b) H3K4 dimethylation of BDNF promoter IV, and c) HDAC1 and mammalian Switch-independent 3 A promoter”
BackgroundPsychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207
Huang, Z. J., Kirkwood, A., Pizzorusso, T., Porciatti, V., Morales, B., Bear, M. F., Maffei, L., & Tonegawa, S. (1999) · Cell · doi:10.1016/s0092-8674(00)81509-3 · Cited by 1,198 · cited 2×
“The outcome is the reopening of a period of structural and functional plasticity within the CNS that can be harnessed therapeutically [182 – 184, 189, 190].”
BackgroundDynamic DNA methylation programs persistent adverse effects of early-life stress
Murgatroyd, C., Patchev, A. V., Wu, Y., Micale, V., Bockmühl, Y., Fischer, D., Holsboer, F., Wotjak, C. T., Almeida, O. F. X., & Spengler, D. (2009) · Nature Neuroscience · doi:10.1038/nn.2436 · Cited by 1,162
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151 · cited 1×
“…[101] and the consolidation of cued fear extinction [102] via a permissive effect over transcription [101], the increased histone acetylation elicited by LSD could be involved in its therapeutic action for alcohol addiction, and distress associated with a life-threatening condition [103 – 106].”
BackgroundAmat, J., Baratta, M. V., Paul, E., Bland, S. T., Watkins, L. R., & Maier, S. F. (2005) · Nature Neuroscience · doi:10.1038/nn1399 · Cited by 931 · cited 2×
“Similarly, and in an opposite fashion, a remodeling of chromatin regions involved with synaptic plasticity, neurotransmission, neurogenesis, and neuroin fl ammation is required in infralimbic and prelimbic neurons to elicit antidepressant effects [1, 9 – 13].”
BackgroundmTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Zou, Z., Tao, T., Li, H., & Zhu, X. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00396-1 · Cited by 927 · cited 1×
“Several of the epigenetic effects elicited by RAADs involve signaling cascades related to cell growth, proliferation, and cancer, such as mTOR and BDNF [252, 253].”
BackgroundZhou, Z., Hong, E. J., Cohen, S., Zhao, W.-N., Ho, H.-Y. H., Schmidt, L., Chen, W. G., Lin, Y., Savner, E., Griffith, E. C., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.037 · Cited by 877 · cited 1×
“Additionally, upon neuronal depolarization, CaMKII-mediated phosphorylation and release of the methyl-binding protein MeCP2 from the BDNF promoter III permits BDNF promoter III-dependent transcription, causing dendritic plasticity in neurons [168, 170].”
BackgroundAn epigenetic blockade of cognitive functions in the neurodegenerating brain
Gräff, J., Rei, D., Guan, J.-S., Wang, W.-Y., Seo, J., Hennig, K. M., Nieland, T. J. F., Fass, D. M., Kao, P. F., Kahn, M., et al. (2012) · Nature · doi:10.1038/nature10849 · Cited by 853 · cited 1×
“Indeed, speci fi c HDACs such as HDAC2 and HDAC5, which are critical regulators of adult neurogenesis [85] and cognition [86], are altered in depression [87].”
BackgroundPostsynaptic Calcium Is Sufficient for Potentiation of Hippocampal Synaptic Transmission
Malenka, R. C., Kauer, J. A., Zucker, R. S., & Nicoll, R. A. (1988) · Science · doi:10.1126/science.2845577 · Cited by 829 · cited 1×
“This process might play a role in the epigenetic effects observed following ketamine administration through altered calcium signaling, leading to increased activity-dependent synaptic plasticity [171 – 173].”
BackgroundGasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000113 · Cited by 750
Long-term follow-up of psilocybin-facilitated smoking cessation
Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2016.1170135 · Cited by 696 · cited 1×
“The long-term improvements in psychiatric symptoms and neuropsychological function elicited by RAADs [19 – 24] are accompanied by enduring serotonergic (such as a peripheral increase of serotonin -5-HT- platelets uptake sites in long-term Ayahuasca users) [25], and neuromorphological changes (such…”
BackgroundNeuronal activity modifies the DNA methylation landscape in the adult brain
Guo, J. U., Ma, D. K., Mo, H., Ball, M. P., Jang, M.-H., Bonaguidi, M. A., Balazer, J. A., Eaves, H. L., Xie, B., Ford, E., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2900 · Cited by 669
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V., Moliner, R., Enkavi, G., Biojone, C., Cannarozzo, C., Sahu, M. P., Kaurinkoski, K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.034 · Cited by 663
Transient cyclical methylation of promoter DNA
Kangaspeska, S., Stride, B., Métivier, R., Polycarpou-Schwarz, M., Ibberson, D., Carmouche, R. P., Benes, V., Gannon, F., & Reid, G. (2008) · Nature · doi:10.1038/nature06640 · Cited by 636
Antidepressant Actions of Histone Deacetylase Inhibitors
Covington, H. E., Maze, I., LaPlant, Q. C., Vialou, V. F., Ohnishi, Y. N., Berton, O., Fass, D. M., Renthal, W., Rush, A. J., Wu, E. Y., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1758-09.2009 · Cited by 624 · cited 1×
“Indeed, speci fi c HDACs such as HDAC2 and HDAC5, which are critical regulators of adult neurogenesis [85] and cognition [86], are altered in depression [87].”
BackgroundA Role for Neuronal piRNAs in the Epigenetic Control of Memory-Related Synaptic Plasticity
Rajasethupathy, P., Antonov, I., Sheridan, R., Frey, S., Sander, C., Tuschl, T., & Kandel, E. R. (2012) · Cell · doi:10.1016/j.cell.2012.02.057 · Cited by 571 · cited 1×
“5-HT signaling also induces changes in the methylation status of the promoter of CREB2, a plasticity-related transcription factor involved in long-term facilitation [177, 178].”
BackgroundPsychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Vollenweider, F. X., & Preller, K. H. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0367-2 · Cited by 570
Rudnick, G., & Wall, S. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1817 · Cited by 535 · cited 1×
“…acid diethylamide (LSD), N, N-Dimethyltryptamine (DMT) and 2,5-Dimethoxy-4-iodoampheta-mine (DOI) [14]; N-Methyl-D-Aspartate (NMDA) antagonists such as ketamine [17]; and empathogens such as 3,4-methylenedioxy-methamphetamine (MDMA), which act mainly through neurotransmitter transporters [18].”
BackgroundThe Hallucinogen N,N -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Fontanilla, D., Johannessen, M., Hajipour, A. R., Cozzi, N. V., Jackson, M. B., & Ruoho, A. E. (2009) · Science · doi:10.1126/science.1166127 · Cited by 535 · cited 2×
“…1) it is actively transported across the blood-brain barrier, 2) acts as a 5-HT transporter substrate on the neuronal plasma membrane, and 3) it is internalized by neuronal cells, and stored into synaptic vesicles by the neuronal vesicle monoamine transporter 2 for up to 1 week [204 – 206].”
BackgroundDecoding the Epigenetic Language of Neuronal Plasticity
Borrelli, E., Nestler, E. J., Allis, C. D., & Sassone-Corsi, P. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.012 · Cited by 525 · cited 1×
“Similarly, and in an opposite fashion, a remodeling of chromatin regions involved with synaptic plasticity, neurotransmission, neurogenesis, and neuroin fl ammation is required in infralimbic and prelimbic neurons to elicit antidepressant effects [1, 9 – 13].”
BackgroundPsychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
Vargas, M. V., Dunlap, L. E., Dong, C., Carter, S. J., Tombari, R. J., Jami, S. A., Cameron, L. P., Patel, S. D., Hennessey, J. J., Saeger, H. N., et al. (2023) · Science · doi:10.1126/science.adf0435 · Cited by 489 · cited 1×
“Indeed, membrane permeability is essential for the neuroplastic effects of psychedelics, and ligand-bound 5-HT 2A receptors are internalized in vivo and in vitro [200 – 203].”
BackgroundGenome-wide epigenetic regulation by early-life trauma
Labonté, B., Suderman, M., Maussion, G., Navaro, L., Yerko, V., Mahar, I., Bureau, A., Mechawar, N., Szyf, M., Meaney, M. J., et al. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2287 · Cited by 488 · cited 1×
“…causes an epigenetic remodeling of stress-responsive DNA and chromatin regions, and associated histone proteins in susceptible brain areas such as the ventral hippocampus [1, 5], amygdala [6], nucleus accumbens (NAc) [7], and the prefrontal cortex (PFC) [8] – dorsal raphe nucleus loop [9 – 11].”
BackgroundReduced genomic 5-methylcytosine content in human colonic neoplasia.
Feinberg, A. P., Gehrke, C. W., Kuo, K. C., & Ehrlich, M. (1988) · PubMed · Cited by 484
Hartogsohn, I. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116677852 · Cited by 483 · cited 1×
“Identifying predictors [266] and modulators (i.e., set and setting, placebo effect) [267] of epigenetic responses accompanying RAADs administration could lead to improved therapeutic precision and ef fi cacy.”
BackgroundMiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants
Baudry, A., Mouillet-Richard, S., Schneider, B., Launay, J.-M., & Kellermann, O. (2010) · Science · doi:10.1126/science.1193692 · Cited by 480
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
Moliner, R., Girych, M., Brunello, C. A., Kovaleva, V., Biojone, C., Enkavi, G., Antenucci, L., Kot, E. F., Goncharuk, S. A., Kaurinkoski, K., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01316-5 · Cited by 478 · cited 2×
“Activation of TRKB signaling results in the activation of other cascades such as the CaMKII, RAS/MAPK and phosphoinositide 3 kinase pathways [14, 17, 186 – 188].”
BackgroundPsilocybin-Occasioned mystical experiences in the treatment of tobacco addiction.
Garcia-Romeu, A., Griffiths, R., & Johnson, M. (2015) · Current Drug Abuse Reviews · doi:10.2174/1874473708666150107121331 · Cited by 476 · cited 1×
“The long-term improvements in psychiatric symptoms and neuropsychological function elicited by RAADs [19 – 24] are accompanied by enduring serotonergic (such as a peripheral increase of serotonin -5-HT- platelets uptake sites in long-term Ayahuasca users) [25], and neuromorphological changes (such…”
BackgroundNew class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites
Lee, I., Ajay, S. S., Yook, J. I., Kim, H. S., Hong, S. H., Kim, N. H., Dhanasekaran, S. M., Chinnaiyan, A. M., & Athey, B. D. (2009) · Genome Research · doi:10.1101/gr.089367.108 · Cited by 476 · cited 1×
“…are transcribed but not translated, with roles in tissue-speci fi c selective or cooperative regulation of splicing, transcription, and translation [111 – 114]. ncRNAs, including stress-responsive ones, are intricately linked to neuroplasticity, psychiatric disorders, and suicide, offering…”
BackgroundHistone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3
Farrelly, L. A., Thompson, R. E., Zhao, S., Lepack, A. E., Lyu, Y., Bhanu, N. V., Zhang, B., Loh, Y.-H. E., Ramakrishnan, A., Vadodaria, K. C., et al. (2019) · Nature · doi:10.1038/s41586-019-1024-7 · Cited by 474 · cited 1×
“Recently, it was reported that 5-HT can covalently bind to glutamine 5 on the trimethylated H3K4 histone, eliciting a permissive transcriptional in fl uence that modulates the interaction of histone PTMs with chromatin readers during neuronal differentiation [109].”
BackgroundBriggs, J. A., Wolvetang, E. J., Mattick, J. S., Rinn, J. L., & Barry, G. (2015) · Neuron · doi:10.1016/j.neuron.2015.09.045 · Cited by 447 · cited 1×
“…are a class of ncRNAs longer than 200 nucleotides with brain area-speci fi c expression patterns involved with neural differentiation and plasticity [165]. lncRNA dynamics are stress-and antidepressant-responsive, are altered in several neuropsychiatric disorders including Major Depressive Disorder…”
BackgroundMithoefer, M. C., Mithoefer, A. T., Feduccia, A. A., Jerome, L., Wagner, M., Wymer, J., Holland, J., Hamilton, S., Yazar-Klosinski, B., Emerson, A., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30135-4 · Cited by 439
DNA methylation of BDNF as a biomarker of early-life adversity
Kundakovic, M., Gudsnuk, K., Herbstman, J. B., Tang, D., Perera, F. P., & Champagne, F. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408355111 · Cited by 426
The role of serotonin 5-HT2A receptors in memory and cognition
Zhang, G., & Stackman, R. W. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00225 · Cited by 382 · cited 1×
“Given that these 5-HT receptors are fundamentally involved in governing cortical circuits mediating cognitive and executive functions [179, 180], the activation of these receptors by RAADs might result in speci fi c epigenomic fi ngerprints and chromatin architecture changes, ultimately leading to…”
BackgroundChromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells
Lim, D. A., Huang, Y.-C., Swigut, T., Mirick, A. L., Garcia-Verdugo, J. M., Wysocka, J., Ernst, P., & Alvarez-Buylla, A. (2009) · Nature · doi:10.1038/nature07726 · Cited by 382
Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565653 · Cited by 381 · cited 1×
“Despite the fact that the use of RAADs has been associated with decreased likelihood of suicide [75, 76], DNA hypermethylation is also observed in the blood of individuals who attempted suicide [77] and in the PFC of suicide completers [78].”
BackgroundPromoter-Wide Hypermethylation of the Ribosomal RNA Gene Promoter in the Suicide Brain
McGowan, P. O., Sasaki, A., Huang, T. C. T., Unterberger, A., Suderman, M., Ernst, C., Meaney, M. J., Turecki, G., & Szyf, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002085 · Cited by 372
BDNF release is required for the behavioral actions of ketamine
Lepack, A. E., Fuchikami, M., Dwyer, J. M., Banasr, M., & Duman, R. S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu033 · Cited by 368
Agin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S., & Ross, S. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119897615 · Cited by 360 · cited 1×
“Considering that psychedelic-assisted psychotherapy is a promising treatment to attenuate psychological and existential distress in individuals facing a life-threatening conditions such as cancer, it is important to assess the neoplastic potential of RAADs [254 – 256].”
BackgroundPsychedelics reopen the social reward learning critical period
Nardou, R., Sawyer, E., Song, Y. J., Wilkinson, M., Padovan-Hernandez, Y., de Deus, J. L., Wright, N., Lama, C., Faltin, S., Goff, L. A., et al. (2023) · Nature · doi:10.1038/s41586-023-06204-3 · Cited by 358 · cited 2×
“The outcome is the reopening of a period of structural and functional plasticity within the CNS that can be harnessed therapeutically [182 – 184, 189, 190].”
BackgroundComparing the DNA Hypermethylome with Gene Mutations in Human Colorectal Cancer
Schuebel, K. E., Chen, W., Cope, L., Glöckner, S. C., Suzuki, H., Yi, J.-M., Chan, T. A., Neste, L. V., Criekinge, W. V., Bosch, S. V. D., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030157 · Cited by 347 · cited 1×
“If RAADs affected DNA methylation and other epigenetic mechanisms indiscriminately, for example by increasing or decreasing global DNA methylation aspeci fi cally, this could pose a risk factor by causing genomic instability or repressing the transcription of tumor-suppressor genes [257 – 259].”
BackgroundValproate Induces Replication-independent Active DNA Demethylation
Detich, N., Bovenzi, V., & Szyf, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303740200 · Cited by 345 · cited 1×
“Epigenetically-active compounds with DNA demethylase activity [45] have antidepressant effects [46, 47], con fi rming that the methylation state and the associated psychiatric symptoms can be reversed pharmacologically [48].”
BackgroundHoward, G., Eiges, R., Gaudet, F., Jaenisch, R., & Eden, A. (2008) · Oncogene · doi:10.1038/sj.onc.1210631 · Cited by 343
The role of 5-HT1A receptors in learning and memory
Ögren, S. O., Eriksson, T. M., Elvander-Tottie, E., D’Addario, C., Ekström, J. C., Svenningsson, P., Meister, B., Kehr, J., & Stiedl, O. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.023 · Cited by 340 · cited 1×
“Given that these 5-HT receptors are fundamentally involved in governing cortical circuits mediating cognitive and executive functions [179, 180], the activation of these receptors by RAADs might result in speci fi c epigenomic fi ngerprints and chromatin architecture changes, ultimately leading to…”
BackgroundDNA methylation is a reversible biological signal
Ramchandani, S., Bhattacharya, S. K., Cervoni, N., & Szyf, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6107 · Cited by 340 · cited 1×
“Epigenetically-active compounds with DNA demethylase activity [45] have antidepressant effects [46, 47], con fi rming that the methylation state and the associated psychiatric symptoms can be reversed pharmacologically [48].”
BackgroundWEAVER, I. C. G., DIORIO, J., SECKL, J. R., SZYF, M., & MEANEY, M. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.099 · Cited by 327
Smalheiser, N. R., Lugli, G., Rizavi, H. S., Torvik, V. I., Turecki, G., & Dwivedi, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033201 · Cited by 324 · cited 1×
“Dysregulated miRNA dynamics are observed in depression and suicide, with studies pinpointing alterations in the PFC and hippocampus during depressive states [121, 122, 128, 129].”
BackgroundIssler, O., Haramati, S., Paul, E. D., Maeno, H., Navon, I., Zwang, R., Gil, S., Mayberg, H. S., Dunlop, B. W., Menke, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.042 · Cited by 318 · cited 1×
“…such as miR-16, miR-124, miR-132, and miR-135 are implicated in antidepressant response, with drugs like fl uoxetine and venlafaxine, imipramine, sertraline, and citalopram modulating their expression, as well as the expression of miR-18a, miR-34a, miR-326, miR-1202 and miR-1971 [117, 130 – 141].”
BackgroundHolze, F., Gasser, P., Müller, F., Dolder, P. C., & Liechti, M. E. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.08.025 · Cited by 318
van Marle, H. J. F., Hermans, E. J., Qin, S., & Fernández, G. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.014 · Cited by 317 · cited 1×
“…causes an epigenetic remodeling of stress-responsive DNA and chromatin regions, and associated histone proteins in susceptible brain areas such as the ventral hippocampus [1, 5], amygdala [6], nucleus accumbens (NAc) [7], and the prefrontal cortex (PFC) [8] – dorsal raphe nucleus loop [9 – 11].”
BackgroundZhou, R., Yuan, P., Wang, Y., Hunsberger, J. G., Elkahloun, A., Wei, Y., Damschroder-Williams, P., Du, J., Chen, G., & Manji, H. K. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.131 · Cited by 316
The signature of maternal rearing in the methylome in rhesus macaque prefrontal cortex and T cells
Provençal, N., Suderman, M. J., Guillemin, C., Massart, R., Ruggiero, A., Wang, D., Bennett, A. J., Pierre, P. J., Friedman, D. P., Côté, S. M., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1470-12.2012 · Cited by 312
Lopez, J. P., Lim, R., Cruceanu, C., Crapper, L., Fasano, C., Labonte, B., Maussion, G., Yang, J. P., Yerko, V., Vigneault, E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3582 · Cited by 308 · cited 1×
“Similarly to what observed with conventional antidepressants [140, 154 – 159] the miRNome might predict the therapeutic response elicited by RAADs.”
ResultRantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301345 · Cited by 305 · cited 1×
“TRKB signaling-mediated epigenetic effects Like classical antidepressants [181], a mechanism that might mediate the epigenetic effects of RAADs is the activation of endogenous BDNF signaling through direct binding to and activation of the TRKB receptor [182 – 185].”
BackgroundAstrocytic abnormalities and global DNA methylation patterns in depression and suicide
Nagy, C., Suderman, M., Yang, J., Szyf, M., Mechawar, N., Ernst, C., & Turecki, G. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.21 · Cited by 301 · cited 2×
“…of genes encoding the glucocorticoid receptor, arginin-vasopressin, and the brain-derived neurotrophic factor (BDNF) can be modulated by early-life adversities as early as 1 day after birth [28 – 43] and speci fi c cell types such as astrocytes carryover the epigenetic marks of stress [35, 44].”
BackgroundEpigenetic Mechanisms of Depression and Antidepressant Action
Vialou, V., Feng, J., Robison, A. J., & Nestler, E. J. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134540 · Cited by 277
Neuropharmacology of N,N-dimethyltryptamine
Carbonaro, T. M., & Gatch, M. B. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.016 · Cited by 268
Ketamine and rapid antidepressant action: New treatments and novel synaptic signaling mechanisms
Krystal, J. H., Kavalali, E. T., & Monteggia, L. M. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-023-01629-w · Cited by 262 · cited 2×
“…acid diethylamide (LSD), N, N-Dimethyltryptamine (DMT) and 2,5-Dimethoxy-4-iodoampheta-mine (DOI) [14]; N-Methyl-D-Aspartate (NMDA) antagonists such as ketamine [17]; and empathogens such as 3,4-methylenedioxy-methamphetamine (MDMA), which act mainly through neurotransmitter transporters [18].”
BackgroundBlood microRNA changes in depressed patients during antidepressant treatment
Bocchio-Chiavetto, L., Maffioletti, E., Bettinsoli, P., Giovannini, C., Bignotti, S., Tardito, D., Corrada, D., Milanesi, L., & Gennarelli, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.06.013 · Cited by 238 · cited 1×
“…or cooperative regulation of splicing, transcription, and translation [111 – 114]. ncRNAs, including stress-responsive ones, are intricately linked to neuroplasticity, psychiatric disorders, and suicide, offering potential as biomarkers and therapeutics for psychiatric disorders [115 – 122].”
BackgroundDopaminylation of histone H3 in ventral tegmental area regulates cocaine seeking
Lepack, A. E., Werner, C. T., Stewart, A. F., Fulton, S. L., Zhong, P., Farrelly, L. A., Smith, A. C. W., Ramakrishnan, A., Lyu, Y., Bastle, R. M., et al. (2020) · Science · doi:10.1126/science.aaw8806 · Cited by 236 · cited 1×
“Lastly, the recently identi fi ed histone PTMs serotonylation and dopaminylation [108 – 110] might potentially be involved in the therapeutic effects of psychedelics, although further investigations are required.”
BackgroundErnst, C., Deleva, V., Deng, X., Sequeira, A., Pomarenski, A., Klempan, T., Ernst, N., Quirion, R., Gratton, A., Szyf, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archpsyc.66.1.22 · Cited by 235 · cited 2×
“…of genes encoding the glucocorticoid receptor, arginin-vasopressin, and the brain-derived neurotrophic factor (BDNF) can be modulated by early-life adversities as early as 1 day after birth [28 – 43] and speci fi c cell types such as astrocytes carryover the epigenetic marks of stress [35, 44].”
BackgroundPsychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232 · cited 4×
“Activation of TRKB signaling results in the activation of other cascades such as the CaMKII, RAS/MAPK and phosphoinositide 3 kinase pathways [14, 17, 186 – 188].”
BackgroundInfluentialSelf-citationKetamine and Peripheral Inflammation
De Kock, M., Loix, S., & Lavand'homme, P. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12104 · Cited by 224 · cited 1×
“Ketamine also decreased miR-451 levels and increased those of the RNA-binding protein hur-6, a de-repressor miRNA “ sponge ” for deleterious miRNAs involved in in fl ammatory responses [124, 145, 146].”
Backgroundde la Fuente Revenga, M., Zhu, B., Guevara, C. A., Naler, L. B., Saunders, J. M., Zhou, Z., Toneatti, R., Sierra, S., Wolstenholme, J. T., Beardsley, P. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109836 · Cited by 224 · cited 5×
“…receptor 2 (mGlu2)-expressing glutamatergic neurons and interneurons, as well as astrocytes of deep-layer prefrontal and somatosensory cortices, the claustrum, and the insula [174], and this activation might be involved in the sustained epigenetic and antidepressant-like effects elicited [107].”
BackgroundInfluentialBouso, J. C., Palhano-Fontes, F., Rodríguez-Fornells, A., Ribeiro, S., Sanches, R., Crippa, J. A. S., Hallak, J. E. C., de Araujo, D. B., & Riba, J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.008 · Cited by 218 · cited 2×
“…of serotonin -5-HT- platelets uptake sites in long-term Ayahuasca users) [25], and neuromorphological changes (such as thinner precuneus and posterior cingulate cortex and thicker anterior cingulate cortex in long-term Ayahuasca users) [26], which suggest the entrainment of epigenetic mechanisms.”
BackgroundBDNF promoter methylation and suicidal behavior in depressive patients
Kang, H.-J., Kim, J.-M., Lee, J.-Y., Kim, S.-Y., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Kim, H.-R., Shin, M.-G., & Yoon, J.-S. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.08.001 · Cited by 218 · cited 1×
“Prenatal and life adversities decrease the promoter IV-mediated BDNF expression via increasing its methylation [36, 43, 49, 51 – 58], and psychiatric disorders largely share increased BDNF promoter methylation, which can be reversed by conventional antidepressants [36, 54 – 61].”
BackgroundMicroglial ERK-NRBP1-CREB-BDNF Signaling in Sustained Antidepressant Actions of (R)-Ketamine
Yao, W., Cao, Q., Luo, S., He, L., Yang, C., Chen, J., Qi, Q., Hashimoto, K., & Zhang, J.-C. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01377-7 · Cited by 216 · cited 2×
“…effects of ketamine might be mediated at least partially via the epigenetic regulation of CREB-BDNF exon IV transcription in the PFC microglia [62] Ketamine reverses the increase in chronic pain-induced hippocampal mRNA and protein levels of the DNA methyltransferase (DNMT) 1, 3a, and 3b.…”
BackgroundGenome-Wide Methylation Changes in the Brains of Suicide Completers
Labonté, B., Suderman, M., Maussion, G., Lopez, J. P., Navarro-Sánchez, L., Yerko, V., Mechawar, N., Szyf, M., Meaney, M. J., & Turecki, G. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050627 · Cited by 212
Ketamine Induces Ferroptosis of Liver Cancer Cells by Targeting lncRNA PVT1/miR-214-3p/GPX4
He, G.-N., Bao, N.-R., Wang, S., Xi, M., Zhang, T.-H., & Chen, F.-S. (2021) · Drug Design, Development and Therapy · doi:10.2147/dddt.s332847 · Cited by 203 · cited 1×
“One investigation found that ketamine elicited ferropoptosis, and may thus elicit anti-neoplastic effects through the lncRNA Pvt1 oncogene /miR-214-3p signaling [263].”
BackgroundChanges in Brain MicroRNAs Contribute to Cholinergic Stress Reactions
Meerson, A., Cacheaux, L., Goosens, K. A., Sapolsky, R. M., Soreq, H., & Kaufer, D. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9252-1 · Cited by 201 · cited 1×
“Early-life and chronic stressors affect the PFC, amygdalar and hippocampal regulatory RNA network, in fl uencing neurotransmission, neuroplasticity, neurogenesis, and behavior [118, 123 – 127].”
BackgroundAyahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
Kuypers, K. P. C., Riba, J., de la Fuente Revenga, M., Barker, S., Theunissen, E. L., & Ramaekers, J. G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4377-8 · Cited by 201
Lopez, J. P., Fiori, L. M., Cruceanu, C., Lin, R., Labonte, B., Cates, H. M., Heller, E. A., Vialou, V., Ku, S. M., Gerald, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15497 · Cited by 201
Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms
Lyles, J., & Cadet, J. L. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00173-5 · Cited by 199 · cited 1×
“These opioidergic effects could have direct implications for the therapeutic effects of MDMA on trauma [233], and for MDMA ’ s potential for addiction and neurotoxicity [234].”
BackgroundKetamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines
Ali, F., Gerhard, D. M., Sweasy, K., Pothula, S., Pittenger, C., Duman, R. S., & Kwan, A. C. (2020) · Nature Communications · doi:10.1038/s41467-019-13809-8 · Cited by 196 · cited 1×
“This process might play a role in the epigenetic effects observed following ketamine administration through altered calcium signaling, leading to increased activity-dependent synaptic plasticity [171 – 173].”
BackgroundD'Addario, C., Dell'Osso, B., Palazzo, M. C., Benatti, B., Lietti, L., Cattaneo, E., Galimberti, D., Fenoglio, C., Cortini, F., Scarpini, E., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.10 · Cited by 192
Self-citationPeripheral whole blood microRNA alterations in major depression and bipolar disorder
Maffioletti, E., Cattaneo, A., Rosso, G., Maina, G., Maj, C., Gennarelli, M., Tardito, D., & Bocchio-Chiavetto, L. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.021 · Cited by 181
DNA methylation of the BDNF gene and its relevance to psychiatric disorders
Ikegame, T., Bundo, M., Murata, Y., Kasai, K., Kato, T., & Iwamoto, K. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.65 · Cited by 179
Integrating the roles of long and small non-coding RNA in brain function and disease
Barry, G. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.196 · Cited by 175 · cited 2×
“Early-life and chronic stressors affect the PFC, amygdalar and hippocampal regulatory RNA network, in fl uencing neurotransmission, neuroplasticity, neurogenesis, and behavior [118, 123 – 127].”
BackgroundBooij, L., Szyf, M., Carballedo, A., Frey, E.-M., Morris, D., Dymov, S., Vaisheva, F., Ly, V., Fahey, C., Meaney, J., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119061 · Cited by 174 · cited 1×
“Antidepressant use increased the peripheral methylation level of the 5-HT transporter [65], and the interleukin (IL)-6 gene [66], as well as telomerase activity in individuals with PTSD [67].”
BackgroundWillins, D. L., Berry, S. A., Alsayegh, L., Backstrom, J. R., Sanders-Bush, E., Friedman, L., & Roth, B. L. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00653-8 · Cited by 171
Bhatnagar, A., Willins, D. L., Gray, J. A., Woods, J., Benovic, J. L., & Roth, B. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006968200 · Cited by 163
Nichols, C. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00405-5 · Cited by 163 · cited 1×
“The increased histone acetylation activity elicited by LSD suggests gene activation, and indeed, LSD activates the transcription [99] of immediate early genes and genes involved with synaptic potentiation and neurotropism in the hippocampus, cortex, midbrain [100], and brainstem [99].”
BackgroundSzyf, M. (2011) · Epigenetics · doi:10.4161/epi.6.8.16793 · Cited by 161 · cited 1×
“This feature shapes the endogenous response to a changing environment via long-term modulation of gene expression [3, 4].”
BackgroundDrugs and addiction: an introduction to epigenetics
Wong, C. C. Y., Mill, J., & Fernandes, C. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03321.x · Cited by 158
Increasing Histone Acetylation in the Hippocampus-Infralimbic Network Enhances Fear Extinction
Stafford, J. M., Raybuck, J. D., Ryabinin, A. E., & Lattal, K. M. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.012 · Cited by 156 · cited 2×
“Given that enhancing hippocampal and PFC histone acetylation ameliorates fear extinction [101] and the consolidation of cued fear extinction [102] via a permissive effect over transcription [101], the increased histone acetylation elicited by LSD could be involved in its therapeutic action for…”
BackgroundTorres-Berrío, A., Lopez, J. P., Bagot, R. C., Nouel, D., Dal Bo, G., Cuesta, S., Zhu, L., Manitt, C., Eng, C., Cooper, H. M., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.08.017 · Cited by 153
Chen, S., Cai, D., Pearce, K., Sun, P. Y.-W., Roberts, A. C., & Glanzman, D. L. (2014) · eLife · doi:10.7554/elife.03896 · Cited by 148 · cited 1×
“5-HT signaling also induces changes in the methylation status of the promoter of CREB2, a plasticity-related transcription factor involved in long-term facilitation [177, 178].”
BackgroundEpigenetic regulation of BDNF expression according to antidepressant response
Lopez, J. P., Mamdani, F., Labonte, B., Beaulieu, M.-M., Yang, J. P., Berlim, M. T., Ernst, C., & Turecki, G. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.38 · Cited by 146 · cited 2×
“Prenatal and life adversities decrease the promoter IV-mediated BDNF expression via increasing its methylation [36, 43, 49, 51 – 58], and psychiatric disorders largely share increased BDNF promoter methylation, which can be reversed by conventional antidepressants [36, 54 – 61].”
BackgroundEspallergues, J., Teegarden, S. L., Veerakumar, A., Boulden, J., Challis, C., Jochems, J., Chan, M., Petersen, T., Deneris, E., Matthias, P., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5634-11.2012 · Cited by 145
Li, W., Ali, T., Zheng, C., Liu, Z., He, K., Shah, F. A., Ren, Q., Rahman, S. U., Li, N., Yu, Z.-J., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02091-5 · Cited by 145 · cited 1×
“…H3 lysine (K)9 and H3K27) hypoacetylation of the BDNF promoters, reverse the stress-induced decrease in BDNF transcription and protein level, promote HDAC5 phosphorylation and nuclear export, and attenuate the stress-induced increase in HDACs in stress-susceptible brain areas [1, 55, 84, 88 – 92].”
BackgroundMicroRNAs as biomarkers for major depression: a role for let-7b and let-7c
Gururajan, A., Naughton, M. E., Scott, K. A., O'Connor, R. M., Moloney, G., Clarke, G., Dowling, J., Walsh, A., Ismail, F., Shorten, G., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.131 · Cited by 144 · cited 2×
“However, in a study in individuals with treatment-resistant depression receiving a ketamine infusion, no signi fi cant effects on whole blood miRNA levels were detected 24 hours after [162].”
BackgroundDavis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118769063 · Cited by 140
BDNF promoter methylation and genetic variation in late-life depression
Januar, V, Ancelin, M.-L., Ritchie, K., Saffery, R., & Ryan, J. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.114 · Cited by 139
Floriou-Servou, A., von Ziegler, L., Stalder, L., Sturman, O., Privitera, M., Rassi, A., Cremonesi, A., Thöny, B., & Bohacek, J. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.02.003 · Cited by 139
De Gregorio, D., Popic, J., Enns, J. P., Inserra, A., Skalecka, A., Markopoulos, A., Posa, L., Lopez-Canul, M., He, Q., Lafferty, C. K., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020705118 · Cited by 139
Self-citationVetencourt, J. F. M., Tiraboschi, E., Spolidoro, M., Castrén, E., & Maffei, L. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07488.x · Cited by 138 · cited 1×
“5-HT triggers a transient remodeling of chromatin structure mediated by 5-HT 1A and BDNF-TRKB signaling which decreases HDAC5 expression, and increases cortical H3K9 acetylation of the BDNF promoter and BDNF levels, reinstating plasticity in the adult nervous system [176].”
BackgroundAllen, A. P., Naughton, M., Dowling, J., Walsh, A., Ismail, F., Shorten, G., Scott, L., McLoughlin, D. M., Cryan, J. F., Dinan, T. G., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.033 · Cited by 138
Psychotherapy with lysergic acid diethylamide
EISNER, B. G., & COHEN, S. (1958) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195812000-00006 · Cited by 138 · cited 1×
“…[101] and the consolidation of cued fear extinction [102] via a permissive effect over transcription [101], the increased histone acetylation elicited by LSD could be involved in its therapeutic action for alcohol addiction, and distress associated with a life-threatening condition [103 – 106].”
BackgroundSchenk, S., Gittings, D., Johnstone, M., & Daniela, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1407-0 · Cited by 137 · cited 1×
“…that psychedelics have low potential for addiction, psychological dependence or reinforcing effects, the NMDA antagonist ketamine [225, 226] and the empathogen MDMA [227, 228] have been associated with drug-seeking behaviors accompanied by epigenetic changes, similarly to drugs of abuse [229, 230].”
BackgroundAyahuasca’s ‘afterglow’: improved mindfulness and cognitive flexibility in ayahuasca drinkers
Murphy-Beiner, A., & Soar, K. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05445-3 · Cited by 135
Chan, J. C., & Maze, I. S. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.05.009 · Cited by 129 · cited 1×
“Lastly, the recently identi fi ed histone PTMs serotonylation and dopaminylation [108 – 110] might potentially be involved in the therapeutic effects of psychedelics, although further investigations are required.”
Backgroundβ-Carboline alkaloids bind DNA
Nafisi, S., Bonsaii, M., Maali, P., Khalilzadeh, M. A., & Manouchehri, F. (2010) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2010.05.005 · Cited by 127 · cited 2×
“…interact with DNA in vitro with af fi nity harmine>harmalol>harmaline>tryptoline β -carbolines might affect chromatin compaction via direct interaction or via interacting with chromatin-remodeling complexes [196] STUDIES ON THE EPIGENETIC EFFECTS OF PSILOCYBIN Main fi ndings Signi fi cance Ref.”
BackgroundJefsen, O. H., Elfving, B., Wegener, G., & Müller, H. K. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120959614 · Cited by 127 · cited 1×
“In accordance, CEBP2 together with several other neuroplasticity-related genes is dose-dependently transcriptionally modulated in the PFC following psilocybin administration [191].”
BackgroundTargeting the BDNF/TrkB pathway for the treatment of tumors (Review)
Meng, L., Liu, B., Ji, R., Jiang, X. M., Yan, X., & Xin, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9854 · Cited by 122 · cited 1×
“Several of the epigenetic effects elicited by RAADs involve signaling cascades related to cell growth, proliferation, and cancer, such as mTOR and BDNF [252, 253].”
BackgroundMao, J., Li, T., Fan, D., Zhou, H., Feng, J., Liu, L., Zhang, C., & Wang, X. (2020) · BMC Psychiatry · doi:10.1186/s12888-019-2374-2 · Cited by 120 · cited 1×
“…expression of 4, and decreased the expression of 1 circRNA, with predicted downstream effects on genes involved in calcium signaling, G protein signaling, protein phosphorylation, Mammalian Target of Rapamycin (mTOR) signaling, transcription, alternative splicing, and neuroplasticity [164].”
BackgroundWojtas, A., Bysiek, A., Wawrzczak‐Bargieła, A., Szych, Z., Majcher‐Maślanka, I., Herian, M., Maćkowiak, M., & Gołembiowska, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126713 · Cited by 119 · cited 2×
“…10 mg/kg increases oxidative DNA damage in the PFC and hippocampus Higher-than clinically-relevant doses of psilocybin elicit DNA damage in the PFC [260] Hypothesis-Psilocybin might affect genetic aging via epigenetic regulation of telomere length Psilocybin might affect epigenetics processes…”
BackgroundRaphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16
Launay, J. M., Mouillet-Richard, S., Baudry, A., Pietri, M., & Kellermann, O. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.54 · Cited by 118 · cited 1×
“…such as miR-16, miR-124, miR-132, and miR-135 are implicated in antidepressant response, with drugs like fl uoxetine and venlafaxine, imipramine, sertraline, and citalopram modulating their expression, as well as the expression of miR-18a, miR-34a, miR-326, miR-1202 and miR-1971 [117, 130 – 141].”
BackgroundTsai, S.-Y. A., Chuang, J.-Y., Tsai, M.-S., Wang, X.-F., Xi, Z.-X., Hung, J.-J., Chang, W.-C., Bonci, A., & Su, T.-P. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518894112 · Cited by 116 · cited 1×
“Whether the sequestered DMT in synaptic vesicles or the DMT-activated Sigma-1 receptor interact with DNA or chromatin remodeling complexes remains to be assessed [206, 207].”
BackgroundO'Connor, R. M., Grenham, S., Dinan, T. G., & Cryan, J. F. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000448 · Cited by 114 · cited 4×
“Ketamine also decreased miR-451 levels and increased those of the RNA-binding protein hur-6, a de-repressor miRNA “ sponge ” for deleterious miRNAs involved in in fl ammatory responses [124, 145, 146].”
BackgroundInfluentialMoreno, J. L., Miranda-Azpiazu, P., García-Bea, A., Younkin, J., Cui, M., Kozlenkov, A., Ben-Ezra, A., Voloudakis, G., Fakira, A. K., Baki, L., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aab0467 · Cited by 114 · cited 1×
“…(i) psyche-delics interact with TRKB, 5-HT 2A , and mGlu2 receptors, that (ii) TRKB interacts with the 5-HT 2A [193] and the mGlu2 [194] receptors, and that (iii) the latter two receptors interact with each other [195], these interactions may be functionally relevant from an epigenetic standpoint.”
BackgroundBerry, S. A., Shah, M. C., Khan, N., & Roth, B. L. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09230-2 · Cited by 110 · cited 1×
“Indeed, membrane permeability is essential for the neuroplastic effects of psychedelics, and ligand-bound 5-HT 2A receptors are internalized in vivo and in vitro [200 – 203].”
BackgroundFrecska, E., Szabo, A., Winkelman, M. J., Luna, L. E., & McKenna, D. J. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1024-y · Cited by 109 · cited 1×
“…1) it is actively transported across the blood-brain barrier, 2) acts as a 5-HT transporter substrate on the neuronal plasma membrane, and 3) it is internalized by neuronal cells, and stored into synaptic vesicles by the neuronal vesicle monoamine transporter 2 for up to 1 week [204 – 206].”
BackgroundThe specific role of histone deacetylase 2 in adult neurogenesis
Jawerka, M., Colak, D., Dimou, L., Spiller, C., Lagger, S., Montgomery, R. L., Olson, E. N., Wurst, W., Göttlicher, M., & Götz, M. (2010) · Neuron Glia Biology · doi:10.1017/s1740925x10000049 · Cited by 109 · cited 1×
“Indeed, speci fi c HDACs such as HDAC2 and HDAC5, which are critical regulators of adult neurogenesis [85] and cognition [86], are altered in depression [87].”
BackgroundRobison, A. J., Vialou, V., Sun, H.-S., Labonte, B., A Golden, S., Dias, C., Turecki, G., Tamminga, C., Russo, S., Mazei-Robison, M., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.319 · Cited by 105 · cited 1×
“Fluoxetine also inhibited the binding of delta-FosB to the Calcium/calmodulin-dependent protein kinase IIa (CaMKIIa) promoter by reducing its acetylation and increasing its H3K9 dimethylation, ultimately decreasing CaMKIIa expression in the NAc [93].”
BackgroundZhang, Y., Wang, Y., Wang, L., Bai, M., Zhang, X., & Zhu, X. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv025 · Cited by 104
Epigenetic Modulation of BDNF Gene in Patients with Major Depressive Disorder
D’Addario, C., Dell’Osso, B. M., Galimberti, D., Palazzo, C., Benatti, B., Francesco, A. D., Scarpini, E. A., Altamura, A. C., & Maccarrone, M. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.07.009 · Cited by 103
Increased DNA methylation in the suicide brain
Haghighi, F., Xin, Y., Chanrion, B., O'Donnell, A. H., Ge, Y., Dwork, A. J., Arango, V., & Mann, J. J. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.3/jmann · Cited by 101 · cited 1×
“Despite the fact that the use of RAADs has been associated with decreased likelihood of suicide [75, 76], DNA hypermethylation is also observed in the blood of individuals who attempted suicide [77] and in the PFC of suicide completers [78].”
BackgroundGregorio, D. D., Inserra, A., Enns, J. P., Markopoulos, A., Pileggi, M., Rahimy, Y. E., López-Canul, M., Comai, S., & Gobbi, G. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01301-9 · Cited by 101
Self-citationA longitudinal study of BDNF promoter methylation and genotype with poststroke depression
Kim, J., Stewart, R. J., Kang, H., Kim, S., Kim, S., Shin, I., Park, M., Kim, H., Shin, M., Cho, K.-H., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.008 · Cited by 100
A Synaptic Locus for TrkB Signaling Underlying Ketamine Rapid Antidepressant Action
Lin, P.-Y., Ma, Z. Z., Mahgoub, M., Kavalali, E. T., & Monteggia, L. M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109513 · Cited by 99 · cited 1×
“Activation of TRKB signaling results in the activation of other cascades such as the CaMKII, RAS/MAPK and phosphoinositide 3 kinase pathways [14, 17, 186 – 188].”
BackgroundCarlberg, L., Scheibelreiter, J., Hassler, M. R., Schloegelhofer, M., Schmoeger, M., Ludwig, B., Kasper, S. F., Aschauer, H. N., Egger, G., & Schosser, A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.07.022 · Cited by 98 · cited 1×
“Prenatal and life adversities decrease the promoter IV-mediated BDNF expression via increasing its methylation [36, 43, 49, 51 – 58], and psychiatric disorders largely share increased BDNF promoter methylation, which can be reversed by conventional antidepressants [36, 54 – 61].”
BackgroundJin, H.-J., Pei, L., Li, Y.-N., Zheng, H., Yang, S., Wan, Y., Mao, L., Xia, Y.-P., He, Q.-W., Li, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13929-5 · Cited by 96
He, S., Liu, X., Jiang, K., Peng, D., Hong, W., Fang, Y., Qian, Y., Yu, S., & Li, H. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.03.015 · Cited by 94
Inserra, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00330 · Cited by 91 · cited 1×
“Speculations exist that Ayahuasca might extinguish the fear response via an epigenetic mechanism mediated by the DMT-activated Sigma-1 receptor [80], although this hypothesis remains to be tested.”
BackgroundSelf-citationmicroRNA-124 targets glucocorticoid receptor and is involved in depression-like behaviors
Wang, S., Mu, R.-H., Li, C., Dong, S., Geng, D., Liu, Q., & Yi, L. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.024 · Cited by 89
The epigenetic effects of antidepressant treatment on human prefrontal cortex BDNF expression
Chen, E. S., Ernst, C., & Turecki, G. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001422 · Cited by 88
Boulle, F., Pawluski, J. L., Homberg, J. R., Machiels, B. M., Kroeze, Y., Kumar, N., Steinbusch, H. W. M., Kenis, G., & van den Hove, D. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.01.017 · Cited by 87 · cited 1×
“While few studies have assessed the transgenerational effects of RAADs, maternal intake during pregnancy and lactation may similarly to conventional antidepressants lead to epigenetic modi fi cations and altered anxiety and depressive-like behavior in the offspring [56, 220 – 222].”
BackgroundThe impact of Ayahuasca on suicidality: results from a randomized controlled trial
Zeifman, R. J., Palhano-Fontes, F., Hallak, J., Arcoverde, E., Maia-Oliveira, J. P., & Araujo, D. B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01325 · Cited by 87
Martin, D. A., & Nichols, C. D. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.049 · Cited by 86 · cited 1×
“…receptor 2 (mGlu2)-expressing glutamatergic neurons and interneurons, as well as astrocytes of deep-layer prefrontal and somatosensory cortices, the claustrum, and the insula [174], and this activation might be involved in the sustained epigenetic and antidepressant-like effects elicited [107].”
BackgroundAltered miRNA expression network in locus coeruleus of depressed suicide subjects
Roy, B., Wang, Q., Palkovits, M., Faludi, G., & Dwivedi, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-04300-9 · Cited by 86 · cited 1×
“Dysregulated miRNA dynamics are observed in depression and suicide, with studies pinpointing alterations in the PFC and hippocampus during depressive states [121, 122, 128, 129].”
BackgroundBDNF genetic variants and methylation: effects on cognition in major depressive disorder
Ferrer, A., Labad, J., Salvat-Pujol, N., Barrachina, M., Costas, J., Urretavizcaya, M., de Arriba-Arnau, A., Crespo, J. M., Soriano-Mas, C., Carracedo, Á., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0601-8 · Cited by 84
Empirical evidence for epigenetic inheritance driving evolutionary adaptation
Stajic, D., & Jansen, L. E. T. (2021) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2020.0121 · Cited by 84 · cited 1×
“This feature shapes the endogenous response to a changing environment via long-term modulation of gene expression [3, 4].”
BackgroundPlatelet serotonin uptake sites increased in drinkers ofayahuasca
Callaway, J. C., Airaksinen, M. M., McKenna, D. J., Brito, G. S., & Grob, C. S. (1994) · Psychopharmacology · doi:10.1007/bf02245347 · Cited by 81 · cited 2×
“…evidence supports the existence of epigenetic mechanisms accompanying the regular consumption of Ayahuasca: increased platelets 5-HT uptake sites [25], thinner precuneus and posterior cingulate cortex, and thicker anterior cingulate cortex [26] were identi fi ed in long term Ayahuasca users.”
BackgroundXu, H., Wang, J., Zhang, K., Zhao, M., Ellenbroek, B. A., Shao, F., & Wang, W. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.11.013 · Cited by 79
Choi, M., Lee, S. H., Wang, S. E., Ko, S. Y., Song, M., Choi, J.-S., Kim, Y.-S., Duman, R. S., & Son, H. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513913112 · Cited by 77 · cited 1×
“This triggers the myocyte enhancer factor 2-mediated transcription of the plasticity-related genes Eukaryotic Translation Initiation Factor 4E Binding Protein 1 (eIF4EBP1) and CREB, and their target genes, and ultimately the onset of antidepressant-like effects [97].”
BackgroundGlobal long non-coding RNA expression in the rostral anterior cingulate cortex of depressed suicides
Zhou, Y., Lutz, P.-E., Wang, Y. C., Ragoussis, J., & Turecki, G. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0267-7 · Cited by 77
Chronic stress and antidepressant induced changes in Hdac5 and Sirt2 affect synaptic plasticity
Erburu, M. M., Muñoz-Cobo, I., Domínguez‐Andrés, J., Beltrán, E., Suzuki, T., Mai, A., Valente, S., Puerta, E., & Tordera, R. M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.08.016 · Cited by 76 · cited 2×
“For example, stress elicits hypoacetylation of hippocampal histone 3 (H3) at BDNF III and IV promoters, and increases the levels of histone deacetylases (HDACs) including HDAC5 and Sirtuin 2, ultimately decreasing BDNF expression [1, 84].”
BackgroundEffects of Perinatal Exposure to Ketamine on the Developing Brain
Cheung, H. M., & Yew, D. T. W. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00138 · Cited by 75 · cited 1×
“For example, ketamine abuse during gestation impacts the epigenetic make-up of the fetus, and can result in impaired neurocognitive function in the offspring [218, 223].”
BackgroundMurphy, T. M., Mullins, N., Ryan, M., Foster, T., Kelly, C., McClelland, R., O'Grady, J., Corcoran, E., Brady, J., Reilly, M., et al. (2013) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2012.00865.x · Cited by 74 · cited 1×
“Despite the fact that the use of RAADs has been associated with decreased likelihood of suicide [75, 76], DNA hypermethylation is also observed in the blood of individuals who attempted suicide [77] and in the PFC of suicide completers [78].”
BackgroundRéus, G. Z., Abelaira, H. M., dos Santos, M. A. B., Carlessi, A. S., Tomaz, D. B., Neotti, M. V., Liranço, J. L. G., Gubert, C., Barth, M., Kapczinski, F. P., et al. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.041 · Cited by 74 · cited 3×
“…pathophysiological sequelae of early-life stress might be partially mediated by a reduction of the stress-induced enhanced accumbal HDAC activity [7] Ketamine enhances HDAC5 Ketamine and other antidepressant strategies modulate hippocampal miRNA pathways such as miR-451 which could be exploited…”
BackgroundKetamine self-administration in the rat: evidence for a critical role of setting
De Luca, M. T., & Badiani, A. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2062-x · Cited by 74 · cited 1×
“…consensus that psychedelics have low potential for addiction, psychological dependence or reinforcing effects, the NMDA antagonist ketamine [225, 226] and the empathogen MDMA [227, 228] have been associated with drug-seeking behaviors accompanied by epigenetic changes, similarly to drugs of…”
BackgroundRuffell, S. G. D., Netzband, N., Tsang, W., Davies, M., Inserra, A., Butler, M., Rucker, J. J. H., Tófoli, L. F., Dempster, E. L., Young, A. H., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.687615 · Cited by 74 · cited 3×
“These changes were accompanied by improved depression and anxiety scores for up to 6 months [79].”
BackgroundInfluentialSelf-citationEnatescu, V. R., Papava, I., Enatescu, I., Antonescu, M., Anghel, A., Seclaman, E., Sirbu, I. O., & Marian, C. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.5.549 · Cited by 73
Boulle, F., Pawluski, J. L., Homberg, J. R., Machiels, B., Kroeze, Y., Kumar, N., Steinbusch, H. W. M., Kenis, G., & Van den Hove, D. L. A. (2016) · Developmental Psychobiology · doi:10.1002/dev.21385 · Cited by 71 · cited 1×
“While few studies have assessed the transgenerational effects of RAADs, maternal intake during pregnancy and lactation may similarly to conventional antidepressants lead to epigenetic modi fi cations and altered anxiety and depressive-like behavior in the offspring [56, 220 – 222].”
BackgroundHung, Y.-Y., Chou, C., Yang, Y.-C., Fu, H., Loh, E.-W., & Kang, H. (2021) · Biomedicines · doi:10.3390/biomedicines9101428 · Cited by 71
Kuang, W.-H., Dong, Z.-Q., Tian, L.-T., & Li, J. (2018) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20187212 · Cited by 70
Yang, X., Yang, Q., Wang, X., Luo, C., Wan, Y., Li, J., Liu, K., Zhou, M., & Zhang, C. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8312-z · Cited by 69 · cited 2×
“A three-day ketamine regimen upregulated 23 miRNAs and downregulated 15 including miR-206 [147] (a negative modulator of BDNF) in vivo Table 1.”
BackgroundMikics, É., Guirado, R., Umemori, J., Tóth, M., Biró, L., Miskolczi, C., Balázsfi, D., Zelena, D., Castrén, E., Haller, J., et al. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.142 · Cited by 68 · cited 1×
“The outcome is the reopening of a period of structural and functional plasticity within the CNS that can be harnessed therapeutically [182 – 184, 189, 190].”
BackgroundWang, J., Zhou, M., Wang, X., Yang, X., Wang, M.-H., Zhang, C., Zhou, S., & Tang, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099855 · Cited by 65 · cited 1×
“In adolescent rats, repeated ketamine high-doses elicited hippocampal apoptosis and cognitive impairments, putatively mediated by hippocampal miR-214 down-regulation/ Phosphatase And Tensin Homolog upregulation [240] and miR-34a upregulation/ Fibroblast Growth Factor Receptor 1 downregulation [241].”
BackgroundLongitudinal associations between BDNF promoter methylation and late-life depression
Kang, H.-J., Kim, J.-M., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Kim, H.-R., Shin, M.-G., & Yoon, J.-S. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.035 · Cited by 65
Noncoding RNAs: Stress, Glucocorticoids, and Posttraumatic Stress Disorder
Daskalakis, N. P., Provost, A. C., Hunter, R. G., & Guffanti, G. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.009 · Cited by 65 · cited 1×
“…but not translated, with roles in tissue-speci fi c selective or cooperative regulation of splicing, transcription, and translation [111 – 114]. ncRNAs, including stress-responsive ones, are intricately linked to neuroplasticity, psychiatric disorders, and suicide, offering potential as…”
BackgroundOokubo, M., Kanai, H., Aoki, H., & Yamada, N. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.028 · Cited by 64
Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse
Cole, J. C., Sumnall, H. R., O’Shea, E., & Marsden, C. A. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1374-x · Cited by 63 · cited 1×
“…that psychedelics have low potential for addiction, psychological dependence or reinforcing effects, the NMDA antagonist ketamine [225, 226] and the empathogen MDMA [227, 228] have been associated with drug-seeking behaviors accompanied by epigenetic changes, similarly to drugs of abuse [229, 230].”
BackgroundSales, A. J., & Joca, S. R. L. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2015.40 · Cited by 62 · cited 1×
“In rodents, chronic fl uoxetine, imipramine, and desipramine blunted the stress-induced increase in hippocampal DNA methylation, and restored the decrease elicited in the PFC [50, 63, 64].”
BackgroundSakata, K., & Duke, S. M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.12.013 · Cited by 60 · cited 1×
“Prenatal and life adversities decrease the promoter IV-mediated BDNF expression via increasing its methylation [36, 43, 49, 51 – 58], and psychiatric disorders largely share increased BDNF promoter methylation, which can be reversed by conventional antidepressants [36, 54 – 61].”
BackgroundSchmidt, U., Herrmann, L., Hagl, K., Novak, B., Huber, C., Holsboer, F., Wotjak, C. T., & Buell, D. R. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00066 · Cited by 60
Gemmel, M., Rayen, I., van Donkelaar, E. L., Loftus, T., Steinbusch, H. W. M., Kokras, N., Dalla, C., & Pawluski, J. L. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.068 · Cited by 60 · cited 1×
“While few studies have assessed the transgenerational effects of RAADs, maternal intake during pregnancy and lactation may similarly to conventional antidepressants lead to epigenetic modi fi cations and altered anxiety and depressive-like behavior in the offspring [56, 220 – 222].”
BackgroundPrefrontal cortex miR-29b-3p plays a key role in the antidepressant-like effect of ketamine in rats
Wan, Y.-Q., Feng, J.-G., Li, M., Wang, M.-Z., Liu, L., Liu, X., Duan, X.-X., Zhang, C.-X., & Wang, X.-B. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0164-4 · Cited by 60 · cited 2×
“The synaptic-potentiating and neurotrophic properties of ketamine might be mediated by speci fi c miRNAs in speci fi c brain areas [142] Ketamine prophylactic treatment in chronically stressed mice affects the level of 32 miRNAs in the PFC; the miRNA with the most signi fi cant change (decrease)…”
BackgroundBinding of Tryptamine and Allied Compounds to Nucleic Acids
Smythies, J., & Antun, F. (1969) · Nature · doi:10.1038/2231061a0 · Cited by 58 · cited 1×
“…DNA double-helix backbone [197] LSD and tryptamines bind to DNA LSD and tryptamines might directly interact with chromatin, affecting gene expression [198] A racemic mixture of l-LSD and d-LSD leads to LSD-DNA Binding. l-LSD but not d-LSD may bind to DNA directly LSD might directly bind DNA [197]”
BackgroundHydroxymethylated Cytosines Are Associated with Elevated C to G Transversion Rates
Supek, F., Lehner, B., Hájková, P., & Warnecke, T. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004585 · Cited by 58 · cited 1×
“Given that cytosine methylation can affect the likelihood of mutations [73, 74] future studies are warranted to investigate the potential effects of the increased DNA methylation elicited by LSD on genomic stability and mutation rates.”
BackgroundWang, P., Zhang, C., Lv, Q., Bao, C., Sun, H., Ma, G., Fang, Y., Yi, Z., & Cai, W. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2463-z · Cited by 58 · cited 1×
“Prenatal and life adversities decrease the promoter IV-mediated BDNF expression via increasing its methylation [36, 43, 49, 51 – 58], and psychiatric disorders largely share increased BDNF promoter methylation, which can be reversed by conventional antidepressants [36, 54 – 61].”
BackgroundDouglas, S. R., Shenoda, B. B., Qureshi, R., Saçan, A., Alexander, G. M., Perreault, M. J., Barrett, J. E., Aradillas, E., Schwartzman, R. J., & Ajit, S. K. (2015) · Journal of Pain · doi:10.1016/j.jpain.2015.05.008 · Cited by 54 · cited 2×
“For example, the non-responder status to ketamine was predicted by lower pretreatment level of miR-548d-5p and miR-605 in individuals with neuropathic pain [160, 161].”
BackgroundJiang, H., Zhang, X., Lu, J., Meng, H., Sun, Y., Yang, X., Zhao, B., & Bao, T. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00102 · Cited by 53
Elevated Serum IgE May be Associated with Development of Ketamine Cystitis
Jhang, J.-F., Hsu, Y.-H., Jiang, Y.-H., & Kuo, H.-C. (2014) · Journal of Urology · doi:10.1016/j.juro.2014.05.084 · Cited by 52 · cited 1×
“…(ii) downregulation of repressive H3K27 and H3K36 trimethylation, and (iii) DNA hypomethylation at nuclear factor-κ B (NF-κ B)-responsive promoters [208, 209], as well as iv) modulation of proin fl ammatory, neurotoxic, and oxidative signaling through RNA regulatory pathways [152, 210 – 216].”
BackgroundVerhoeven, J. E., Yang, R., Wolkowitz, O. M., Bersani, F. S., Lindqvist, D., Mellon, S. H., Yehuda, R., Flory, J. D., Lin, J., Abu-Amara, D., et al. (2018) · Complex Psychiatry · doi:10.1159/000491431 · Cited by 51 · cited 1×
“Antidepressant use increased the peripheral methylation level of the 5-HT transporter [65], and the interleukin (IL)-6 gene [66], as well as telomerase activity in individuals with PTSD [67].”
BackgroundThe long noncoding RNA FEDORA is a cell type– and sex-specific regulator of depression
Issler, O., van der Zee, Y. Y., Ramakrishnan, A., Xia, S.-H., Zinsmaier, A. K., Tan, C., Li, W., Browne, C. J., Walker, D. M., Salery, M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn9494 · Cited by 51
Role of miR‐34c in ketamine‐induced neurotoxicity in neonatal mice hippocampus
Cao, S., Tian, J., Chen, S., Zhang, X., & Zhang, Y. (2015) · Cell Biology International · doi:10.1002/cbin.10349 · Cited by 50 · cited 2×
“…Repeated ketamine administration in the neonatal period elicits hippocampal neurotoxicity at least partially through miR-34c upregulation [236] miR-34a overexpression reverses the neurological and cognitive de fi cits, histopathological brain changes, and exacerbation of circulating proin…”
BackgroundThe Class I HDAC inhibitor RGFP963 enhances consolidation of cued fear extinction
Bowers, M. E., Xia, B., Carreiro, S., & Ressler, K. J. (2015) · Learning & Memory · doi:10.1101/lm.036699.114 · Cited by 50 · cited 1×
“Given that enhancing hippocampal and PFC histone acetylation ameliorates fear extinction [101] and the consolidation of cued fear extinction [102] via a permissive effect over transcription [101], the increased histone acetylation elicited by LSD could be involved in its therapeutic action for…”
BackgroundZheng, X., Lin, C., Li, Y., Ye, J., Zhou, J., & Guo, P. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.05.050 · Cited by 50 · cited 2×
“…ketamine-induced apoptosis and promotes neurite outgrowth The neurotoxic effects of ketamine in vitro might be mediated by a modulation of BDNF-AS [251] Repeated high-dose ketamine upregulates hippocampal miR-34a, which targets the Fibroblast Growth Factor Receptor 1 (FGR1) gene, and elicits…”
BackgroundLopez, J. P., Pereira, F., Richard-Devantoy, S., Berlim, M., Chachamovich, E., Fiori, L. M., Niola, P., Turecki, G., & Jollant, F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.9 · Cited by 50
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease
Tagen, M., Mantuani, D., van Heerden, L., Holstein, A., Klumpers, L. E., & Knowles, R. G. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231190865 · Cited by 48 · cited 1×
“Given the concern surrounding the potential impact of RAADs on cardio-vascular function through cardiac 5-HT receptors [219], future investigations are recommended to explore potential deleterious effects at clinically relevant doses and regimens.”
BackgroundSales, A. J., & Joca, S. R. L. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.01.022 · Cited by 47 · cited 3×
“Stressors also affect the regulation of DNA-methylating enzymes such as DNMT3a and 3b [49] in stress-susceptible brain areas such as the PFC and hippocampus [35, 44, 50].”
BackgroundLeonhardt, M., Sellmer, A., Krämer, O. H., Dove, S., Elz, S., Kraus, B., Beyer, M., & Mahboobi, S. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.04.046 · Cited by 47 · cited 1×
“The β -carbolines contained in the Ayahuasca brew might also inhibit histone deacetylase activity, given that engineered derivatives containing β -carbolines motifs are potent HDACs inhibitors [81, 82].”
BackgroundInserra, A., Campanale, A., Cheishvili, D., Dymov, S., Wong, A. H. Y., Marçal, N., Syme, R. A., Taylor, L., Gregorio, D. D., Kennedy, T. E., et al. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110594 · Cited by 47 · cited 5×
“Repeated LSD largely increased the methylation level of 635 CpG sites in the PFC of adult male mice receiving a prosocial, anxiolytic, and synaptoplastic repeated regimen of LSD [69 – 72].”
BackgroundInfluentialSelf-citationLong noncoding RNAs in psychiatric disorders
Zuo, L., Tan, Y., Wang, Z., Wang, K.-S., Zhang, X., Chen, X., Li, C.-S. R., Wang, T., & Luo, X. (2016) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000129 · Cited by 46 · cited 2×
“Early-life and chronic stressors affect the PFC, amygdalar and hippocampal regulatory RNA network, in fl uencing neurotransmission, neuroplasticity, neurogenesis, and behavior [118, 123 – 127].”
BackgroundMa, L., Wang, L., Chang, L., Shan, J., Qu, Y., Wang, X., Fujita, Y., & Hashimoto, K. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109250 · Cited by 45 · cited 3×
“The PFC levels of selected miRNA affected by ketamine correlate to the abundance of speci fi c gut microbiome taxa [152] Ketamine increases the hippocampal (but not PFC) transcription of a cluster of miRNAs (764-5p, 1912-3p, 1264-3p, 1298-5p, and 448-3p) hosted in the 5-HT 2C gene locus through…”
BackgroundMa, L., Wang, L., Chang, L., Shan, J., Qu, Y., Wang, X., Wan, X., Fujita, Y., & Hashimoto, K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02192-6 · Cited by 45 · cited 2×
“…antidepressant effects of ketamine, potentially through its regulatory effects on the expression of BDNF, TGF-β 1, and MeCP2 in the PFC [144] Acute ketamine administration increases the PFC levels of miR-219a-5p, miR-7a-5p, miR-181b-5p and miR-148a-3p and decreases the levels of…”
BackgroundIn vitro Interaction of LSD with Purified Calf Thymus DNA
Wagner, T. E. (1969) · Nature · doi:10.1038/2221170b0 · Cited by 44 · cited 3×
“Indeed, the β -carbolines contained in the brew Ayahuasca directly interact with DNA in vitro [196], and early studies observed that LSD directly binds DNA or histone proteins [197 – 199].”
BackgroundInserra, A., Giorgini, G., Lacroix, S., Bertazzo, A., Choo, J. M., Markopolous, A., Grant, E., Abolghasemi, A., Gregorio, D. D., Flamand, N., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15977 · Cited by 44 · cited 1×
“Repeated LSD largely increased the methylation level of 635 CpG sites in the PFC of adult male mice receiving a prosocial, anxiolytic, and synaptoplastic repeated regimen of LSD [69 – 72].”
BackgroundSelf-citationAntidepressant-like effect of valproic acid—Possible involvement of PI3K/Akt/mTOR pathway
Lima, I. V. D. A., Almeida-Santos, A. F., Ferreira-Vieira, T. H., Aguiar, D. C., Ribeiro, F. M., Campos, A. C., & de Oliveira, A. C. P. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.015 · Cited by 43 · cited 1×
“Epigenetically-active compounds with DNA demethylase activity [45] have antidepressant effects [46, 47], con fi rming that the methylation state and the associated psychiatric symptoms can be reversed pharmacologically [48].”
BackgroundJu, L.-S., Yang, J.-J., Lei, L., Xia, J.-Y., Luo, D., Ji, M.-H., Martynyuk, A. E., & Yang, J.-J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00100 · Cited by 43 · cited 4×
“Prenatal and life adversities decrease the promoter IV-mediated BDNF expression via increasing its methylation [36, 43, 49, 51 – 58], and psychiatric disorders largely share increased BDNF promoter methylation, which can be reversed by conventional antidepressants [36, 54 – 61].”
BackgroundInfluentialLin, C.-C., Tsai, M.-C., Lee, C.-T., Sun, M.-H., & Huang, T.-L. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.09.025 · Cited by 43
Rasheed, M., Asghar, R., Firdoos, S., Ahmad, N., Nazir, A., Ullah, K. M., Li, N., Zhuang, F., Chen, Z., & Deng, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031294 · Cited by 43 · cited 2×
“…or cooperative regulation of splicing, transcription, and translation [111 – 114]. ncRNAs, including stress-responsive ones, are intricately linked to neuroplasticity, psychiatric disorders, and suicide, offering potential as biomarkers and therapeutics for psychiatric disorders [115 – 122].”
BackgroundToffoli, L. V., Rodrigues, G. M., de Oliveira, J. F., Silva, A. S., Moreira, E. G., Pelosi, G. G., & Gomes, M. V. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.031 · Cited by 42
Altered expression of long noncoding RNAs in patients with major depressive disorder
Seki, T., Yamagata, H., Uchida, S., Chen, C., Kobayashi, A., Kobayashi, M., Harada, K., Matsuo, K., Watanabe, Y., & Nakagawa, S. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.07.004 · Cited by 42 · cited 1×
“…fi c expression patterns involved with neural differentiation and plasticity [165]. lncRNA dynamics are stress-and antidepressant-responsive, are altered in several neuropsychiatric disorders including Major Depressive Disorder (MDD), and might predict the antidepressant response [118, 127, 166].”
BackgroundA Longitudinal Study of BDNF Promoter Methylation and Depression in Breast Cancer
Kang, H.-J., Kim, J.-M., Kim, S.-Y., Kim, S.-W., Shin, I.-S., Kim, H.-R., Park, M.-H., Shin, M.-G., Yoon, J.-H., & Yoon, J.-S. (2015) · Psychiatry Investigation · doi:10.4306/pi.2015.12.4.523 · Cited by 40
(2015) · PubMed Central · Cited by 40
Potential Use of MicroRNA for Monitoring Therapeutic Response to Antidepressants
Belzeaux-R, R., Lin, R., & Turecki, G. (2017) · CNS Drugs · doi:10.1007/s40263-017-0418-z · Cited by 40 · cited 1×
“Dysregulated miRNA dynamics are observed in depression and suicide, with studies pinpointing alterations in the PFC and hippocampus during depressive states [121, 122, 128, 129].”
Background
Cited by
Pardossi, S., Fagiolini, A., & Cuomo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313098 · Cited by 51
Psychedelics in neuroinflammation: Mechanisms and therapeutic potential
de Deus, J. L., Maia, J. M., Soriano, R. N., Amorim, M. R., & Branco, L. G. S. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111278 · Cited by 40
The science of psychedelic medicine
Siegel, J. S., Liston, C. M., Nicol, G. E., Carhart-Harris, R. L., & Bogenschutz, M. P. (2026) · Nature Medicine · doi:10.1038/s41591-025-04194-5 · Cited by 29
“It may also be possible to measure epigenetic modifications in circulating cells that reflect transcriptional programs relevant to plasticity 90,91 .”
Werle, I., & Bertoglio, L. J. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105899 · Cited by 26
Psilocybin treatment extends cellular lifespan and improves survival of aged mice
Kato, K., Kleinhenz, J., Shin, Y.-J., Coarfa, C., Zarrabi, A. J., & Hecker, L. (2025) · npj Aging · doi:10.1038/s41514-025-00244-x · Cited by 22
“Priorstudieshavedemonstratedthat thelong-lastingimpactsofpsychedelictreatmentsmaybedueto epigenomic-drivenalterations,includingchromatinremodelingandDNA methylation 19 – 21 .”
Metadata
- Authors
- Inserra, A., Campanale, A., Rezai, T., Romualdi, P., & Rubino, T.
- Affiliations
- Universidade do Sul de Santa Catarina (BR)
- McGill University (CA)
- University of Bologna (IT)
- University of Insubria (IT)
- Corresponding author
- Inserra, Antonio
- Venue
- Translational Psychiatry
- Published
- 2024-09-04
- Volume
- 14
- Issue
- 1
- Pages
- 359-359
- ISSN
- 2158-3188 (ISSN-L)
- PMC
- PMC11375021
- OpenAlex
- W4402221259
- Cited by
- 27
- References
- 272
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 2
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Translational Psychiatry (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IrInSubria (University of Insubria) (submittedVersion)
- Funders
- Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre
- Fonds de Recherche du Québec-Société et Culture
- Quebec Autism Research Training Program
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- rapid-acting antidepressants, epigenetics, dissociative anesthetics, psychedelics, DNA methylation, histone modifications, non-coding RNA, neuroplasticity, neurotrophism, serotonin signaling, TrkB signaling, chromatin remodeling, neuroepigenetics, depression treatment
- MeSH terms
- Animals, Antidepressive Agents, Brain, Histones, Humans, Neuronal Plasticity, Stress, Psychological, DNA Methylation, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.